Showing 13,381 - 13,400 results of 48,899 for search '(( a ((mean decrease) OR (linear decrease)) ) OR ( a ((greatest decrease) OR (largest decrease)) ))', query time: 0.97s Refine Results
  1. 13381

    Screen of articles. by Ziyi Li (349831)

    Published 2023
    “…<div><p>Background</p><p>The incidence of heart failure (HF) is increasing year by year, posing a great threat to human health. Although pharmacotherapy has been able to significantly prolong patient survival, pharmacotherapy for HF still has limitations due to its complex pathogenesis and considerable individual variability, there is a great need to explore complementary and alternative therapies to slow down the progression of HF. …”
  2. 13382

    Risk of bias graph. by Ziyi Li (349831)

    Published 2023
    “…<div><p>Background</p><p>The incidence of heart failure (HF) is increasing year by year, posing a great threat to human health. Although pharmacotherapy has been able to significantly prolong patient survival, pharmacotherapy for HF still has limitations due to its complex pathogenesis and considerable individual variability, there is a great need to explore complementary and alternative therapies to slow down the progression of HF. …”
  3. 13383

    Risk of bias summary. by Ziyi Li (349831)

    Published 2023
    “…<div><p>Background</p><p>The incidence of heart failure (HF) is increasing year by year, posing a great threat to human health. Although pharmacotherapy has been able to significantly prolong patient survival, pharmacotherapy for HF still has limitations due to its complex pathogenesis and considerable individual variability, there is a great need to explore complementary and alternative therapies to slow down the progression of HF. …”
  4. 13384

    The characteristics of the included studies. by Ziyi Li (349831)

    Published 2023
    “…<div><p>Background</p><p>The incidence of heart failure (HF) is increasing year by year, posing a great threat to human health. Although pharmacotherapy has been able to significantly prolong patient survival, pharmacotherapy for HF still has limitations due to its complex pathogenesis and considerable individual variability, there is a great need to explore complementary and alternative therapies to slow down the progression of HF. …”
  5. 13385
  6. 13386
  7. 13387
  8. 13388
  9. 13389
  10. 13390
  11. 13391
  12. 13392
  13. 13393
  14. 13394
  15. 13395
  16. 13396
  17. 13397

    Safety and efficacy of low dose pioglitazone compared with standard dose pioglitazone in type 2 diabetes with chronic kidney disease: A randomized controlled trial by Bancha Satirapoj (726102)

    Published 2018
    “…The mean changes in HbA1c for standard and low dose pioglitazone were 1.1±1.6 and -1.4±1.5 (<i>P</i> = 0.543), respectively. …”
  18. 13398
  19. 13399
  20. 13400